Study Confirms Link Between Smoking and ALS
Medically reviewed by Drugs.com.
By Ernie Mundell HealthDay Reporter
TUESDAY, Jan. 30, 2024 -- New research is helping confirm smoking as a risk factor for the devastating brain illness amyotrophic lateral sclerosis (ALS).
ALS affects roughly 31,000 Americans each year, with about 5,000 new cases diagnosed annually, according to the U.S. Centers for Disease Control and Prevention. It's a progressive, fatal illness that causes nerves cells controlling muscles to slowly die, leading to weakness and paralysis.
The causes of ALS are unknown, and even risk factors for the disease remain unclear.
In their new research, a team from South Korea looked at the data from 32 different studies for possible links between smoking and ALS.
They found that people who had smoked had a 12% higher odds of developing ALS compared to those who hadn't, with risks rising even higher if the person was a current smoker.
“One of our most pivotal findings was the dose-response analysis, revealing an inverted U-shaped curve,” said study lead author Dr. Yun Hak Kim, of the department of biomedical informatics at Pusan National University in Busan, Korea.
According to Kim, a U-shaped curve means that the “risk associated with smoking isn't a linear progression."
"Instead, it peaks and then starts to decrease or plateau, suggesting that the risk of ALS is influenced by the intensity of smoking," he said in a university news release.
Gender seemed to play a role as well.
The link between smoking and ALS appeared stronger for women smokers, who had a 20% higher odds for the disease than women who hadn't smoked. After adjusting for other potential risk factors, that added risk rose to 25%, the study found.
The findings were published in the January issue of the journal Tobacco Induced Diseases.
There are lots of great reasons to quit smoking, and now "encouraging individuals to discontinue smoking is crucial, given its tangible impact on reducing the likelihood of ALS onset," the researchers said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-30 22:15
Read more
- UroGen Announces FDA Acceptance of its New Drug Application for UGN-102
- Volixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis
- Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs
- Vaping Rates Hit Record Lows for U.S. High School Students
- Costs for MS, Parkinson's and Alzheimer's Meds Keep Rising
- Smoking Tied to Increased Opioid Use
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions